Elliniko Instituto Meletis Tis Sipsis

Elliniko Instituto Meletis Tis Sipsis is an SME in Athens, Greece that has taken part in 6 EU-funded projects since 2019, receiving €5.5M in EU funding.

EU funding received€5.5M
EU projects6
As coordinator0
Running now3
First EU project2019
Latest project2026
CountryGreece
EU registration (PIC)948672126
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Elliniko Instituto Meletis Tis Sipsis's own share of each project, not the project's full budget.

  • Horizon Europe€2.8M · 4 projects
  • Horizon 2020€2.6M · 2 projects

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • HEAL-4WARDAssociated partner

    HEAL-4WARD - doctoral network for Wound infection Advanced care and Rapid Diagnosis

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • Homi-lungPartner

    Long-term alterations of host-microbiome interactions and cardiovascular and respiratory diseases progression after pneumonia

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €897ktheir share
  • POINTPartner

    Preventing non-communicable diseases caused by the post-acute phase of cOvid-19 INfecTion

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €1.2Mtheir share
  • EPIC-CROWN-2Partner

    Equine Polyclonal antibodies Immunotherapy against COVID-19/SARS-CoV2–VOC

    Horizon Europe · 2021–2023 · Project on CORDIS ↗

    €717ktheir share
  • ImmunoSepPartner

    Personalized immunotherapy in sepsis: a precision medicine based approach

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €2.4Mtheir share
  • TRAIN-OLDPartner

    Trained immunity: improving the next generation of vaccines for the older generation

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €238ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • antibiotic resistance
  • antibiotics
  • cardiovascular diseases
  • coronaviruses
  • critical care medicine
  • epigenomes
  • genetic engineering
  • genomes
  • immunology
  • immunotherapy
  • metabolomes
  • microbiology
  • mortality
  • nano-materials

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime